RecruitingPhase 3NCT03131726

Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)


Sponsor

Lund University

Enrollment

80 participants

Start Date

Jan 26, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

In an investigator initiated multicenter trial (Malmö, Odense, Århus) the investigators aim at evaluating activity of Graves´ophthalmopathy (GO) and progress to severe GO in patients with mild to moderate Graves´ ophthalmopathy treated with simvastatin or no treatment.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Inclusion Criteria3

  • Age 18-70 years
  • Active mild to moderate with at least one sign of mild GO (NO SPECS class 2a and b) with reference to Colour Atlas at EUGOGO website (www.eugogo.eu). Exophthalmos up to 24 mm with a disease duration of \<18 months (as recorded by the patient)
  • Graves´ disease with clinical and laboratory euthyroidism after stopping treatment with anti thyroid drugs (ATD), or 2 months treatment with ATD, or euthyroid 6 months after treatment with radioiodine, or euthyroid after total thyroidectomy. Clinical and laboratory euthyroidism is defined as normal fT4, fT3 and TSH below the upper limit of the local reference interval and no clinical symptoms or signs of hyperthyroidism. L-thyroxine is used to achieve euthyroidism during the study period.

Exclusion Criteria13

  • Pregnancy or breast-feeding
  • Previous treatment of Graves´ ophthalmopathy
  • Severe Graves ophthalmopathy requiring corticosteroid treatment, retrobulbar irradiation, orbital decompression surgery
  • Current or previous treatment with simvastatin or other statins (within 3 months)
  • Allergy (skin rash or systemic reactions) to statins
  • Congestive heart failure
  • Renal insufficiency (glomerular filtration rate \<60 ml/min)
  • ASAT or ALAT \> 2.5 times the upper limit of the local laboratory
  • Alcoholism as judged by local criteria
  • Coagulopathy including treatment with warfarin or new oral anti-coagulation drugs
  • Previous or current gastric ulcer
  • Inflammatory bowel disease diabetic retinopathy or nephropathy
  • Trauma within 10 days

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGSimvastatin 40mg

see arm description


Locations(1)

Dpt. of Endocrinology, SUS Malmö

Malmo, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03131726


Related Trials